| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/23/2004 | WO2004037847A3 Hiv envelope-cd4 complexes and hybrids |
| 09/23/2004 | WO2004029575A3 Methods for diagnosing htlv-i-mediated diseases |
| 09/23/2004 | WO2004016231A3 PROTECTION OF PATIENTS LACKING A FUNCTIONAL SPLEEN AGAINST S. PNEUMONIAE WITH PNEUMOCOCCAL SURFACE PROTEIN A (PspA) |
| 09/23/2004 | WO2004010947A3 Humanized antibodies against human 4-1bb |
| 09/23/2004 | WO2004009782A3 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003102157A3 Synthetic antibody phage libraries |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003072017A3 Macromolecular conjugates and processes for preparing same |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003046204A3 Humanized collagen antibodies and related methods |
| 09/23/2004 | WO2003029262A3 The human mob-5 (il-24) receptors and uses thereof |
| 09/23/2004 | WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186274 Methylation of histone h4 at arginine 3 |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185536 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 09/23/2004 | US20040185530 Novel thermophilic polymerase III holoenzyme |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185476 antibody microarray for detecting incomplete deprotection of synthetic test oligonucleotides; high throughput assay; solid phase synthesis |
| 09/23/2004 | US20040185465 for diagnosing a disease in an animal or susceptibility to a disease related to an over-expression of a phosphodiesterase; for drug screening antiinflammatory agents |
| 09/23/2004 | US20040185460 kits for drug screening by gel-shift assay, western blot, phage-based expression cloning, co-fractionation by chromatography, co-precipitation, cross linking, interaction trap/two hybrid analysis, and enzyme linked immunosorbent assay (ELISA) |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185061 Redox reversible HCV proteins with native-like conformation |
| 09/23/2004 | US20040185054 Chemically programmable immunity |
| 09/23/2004 | US20040185052 Antitumor agents; leukemia; |
| 09/23/2004 | US20040185051 Monoclonal or polyclonal antibody that binds to antigens of Stachybotrys |
| 09/23/2004 | US20040185050 Administering antimalarial agent to interfere with infection of hepatocytes by Plasmodium such as primaquine; preventing spread in vivo |
| 09/23/2004 | US20040185049 Administering to animal an interleukin-27R/cytokine receptor (IL-27R/WSX-1) ligand to treat autoimmune diseases; antiasthmatics, antiallergens, and antiinflammatory agents; diabetes |
| 09/23/2004 | US20040185047 Anti- TNF antibodies, compositions, methods and uses |
| 09/23/2004 | US20040185046 Methods of treating autoimmune disease via CTLA-4Ig |
| 09/23/2004 | US20040185045 FcgammaRIIB-specific antibodies and methods of use thereof |
| 09/23/2004 | US20040185044 Use of human antibody which recognises apolipoprotein CIII; atherosclerosis or dyslipidaemia treatment; passive vaccination |
| 09/23/2004 | US20040185043 Administering agent that depletes alpha beta -, and gamma delta -TCR+ T cells and/or CD8+ T cells; transplantation with hematopoietic stem cells from donor matched at the major histocompatibility complex class I K locus; grafting |
| 09/23/2004 | US20040185042 method for highly selective removal of anti-vWF-cp-abs from human plasma using adsorbent comprises hvWF-cp or fragments thereof, coupled to an inert matrix material |
| 09/23/2004 | US20040185040 Modulating immune responses |
| 09/23/2004 | US20040185039 Autophilically-modified antibodies bind to their respective tumor target cells with increased efficiency |
| 09/23/2004 | US20040184990 Receptor binding conjugates |
| 09/23/2004 | DE10310261A1 Identifizierung von Antigen-Epitopen Identification of antigen epitopes |
| 09/23/2004 | CA2529819A1 Pegylated single domain antibodies |
| 09/23/2004 | CA2519105A1 Monoclonal antibody and hybridoma producing the same |
| 09/23/2004 | CA2518957A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | CA2518944A1 Inhibitors of extracellular hsp90 |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518787A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | CA2518275A1 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | CA2518262A1 Uses of il-23 agonists and antagonists; related reagents |
| 09/22/2004 | EP1460133A1 Nucleic acids with the aid of which plants having an altered metabolite content can be produced |
| 09/22/2004 | EP1460132A1 Antibodies with specific immunoreactivity to thyroid carcinoma cells |
| 09/22/2004 | EP1460088A1 Humanized anti-CD4 antibody with immunosuppressive properties |
| 09/22/2004 | EP1460087A1 Methods of treating vascular disease with TNF antagonists |
| 09/22/2004 | EP1459768A2 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 09/22/2004 | EP1459761A1 A pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1458885A2 The use of histamine h4 receptor antagonist for the treatment of inflammatory response |
| 09/22/2004 | EP1458874A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458759A2 Human antibodies against human glycoprotein vi and their use |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458749A2 Bone polypeptide-1 |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458230A1 Production of recombinant antibodies by means of fusion with elastin-like peptides |
| 09/22/2004 | EP1409713A4 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 09/22/2004 | EP1337546A4 Method for detecting hematopoietic stem cells |
| 09/22/2004 | EP1284989A4 Separation of avian antibodies |
| 09/22/2004 | EP1218396B1 Antibodies specific for fullerenes |
| 09/22/2004 | EP1173766B1 A tenascin-c isoform as a marker for neoplasias |
| 09/22/2004 | EP1112500B1 Tau as a marker for early cns damage |
| 09/22/2004 | EP1096955B1 Uses of antibodies to aminophospholipids for cancer treatment |
| 09/22/2004 | EP1009756B1 RECOMBINANT IgA |
| 09/22/2004 | EP0941121B1 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
| 09/22/2004 | EP0915970B1 Type c lectins |
| 09/22/2004 | EP0742822B1 Folding proteins |
| 09/22/2004 | EP0726914B1 Cell surface protein expressed on human cortical thymocyte and their use |
| 09/22/2004 | EP0706571B1 Tuberculosis vaccine |
| 09/22/2004 | EP0587805B2 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin |
| 09/22/2004 | CN1531552A Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531545A Reducing immunogenicity of fusion proteins |
| 09/22/2004 | CN1167795C Novel peptide, novel DNA and novel antibody |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/21/2004 | US6794501 Colon cancer antigen panel |
| 09/21/2004 | US6794500 RNA-binding protein |
| 09/21/2004 | US6794496 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 09/21/2004 | US6794494 Can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells; for diagnosis and therapy of primary tumors |
| 09/21/2004 | US6794491 Polypeptides, their production and use |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/21/2004 | US6794192 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6794153 Detecting microorganism in sample; obtain sample, incubate with dissociation agent, incubate with antibody, incubate with affinity column, detect bound agent |